{"disease":{"id":"hypermobile-eds-heds","name":"hypermobile eds heds"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05434728","title":"Characterization of Bleeding Disorders in EDS","phase":"","overall_status":"UNKNOWN","enrollment_count":45,"lead_sponsor_name":"University Health Network, Toronto","has_results":false},{"nct_id":"NCT04972565","title":"Dyspnea in Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorder","phase":"NA","overall_status":"COMPLETED","enrollment_count":34,"lead_sponsor_name":"University Health Network, Toronto","has_results":false},{"nct_id":"NCT06548594","title":"Out of State - tAN hEDS","phase":"NA","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Medical University of South Carolina","has_results":false},{"nct_id":"NCT05429996","title":"Ultrastructural Collagen Markers in Ehlers Danlos Syndromes","phase":"","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"University Health Network, Toronto","has_results":false},{"nct_id":"NCT04734041","title":"Integrative Medicine for Hypermobility Spectrum Disorder and Ehlers-Danlos Syndromes (IMforHSDandEDS)","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"National University of Natural Medicine","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}